A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants

NCT02713061 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda